Enzon Pharmaceuticals, Inc. (BST:EZ1)
Germany
· Delayed Price · Currency is EUR 0.0755
-0.0040 (-5.03%)
At close: Jul 3, 2025
Enzon Pharmaceuticals Revenue
Enzon Pharmaceuticals had revenue of $26.00K USD in the twelve months ending March 31, 2025. In the year 2024, Enzon Pharmaceuticals had annual revenue of $26.00K.
Revenue
$26.00K
Revenue Growth
n/a
P/S Ratio
301.39
Revenue / Employee
$26.00K
Employees
1
Market Cap
7.25M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 26.00K | -675.00K | -96.29% |
| Dec 31, 2021 | 701.00K | 649.00K | 1,248.08% |
| Dec 31, 2020 | 52.00K | -155.00K | -74.88% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.15B |
| Siemens Aktiengesellschaft | 77.82B |
| Deutsche Telekom AG | 120.25B |
| Allianz SE | 109.03B |
| Rheinmetall AG | 10.48B |
| Siemens Energy AG | 37.44B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
| Siemens Healthineers AG | 23.14B |